First Personalized CRISPR Treatment Gives Baby New Lease on Life
SMRTR summary
A baby boy with a rare genetic disease received a groundbreaking CRISPR therapy tailored to his specific mutation. The treatment, developed in just six months, has allowed KJ Muldoon to thrive at 10 months old. While promising, it's too early to call it a cure. This personalized approach could inspire similar treatments for ultra-rare genetic disorders, but scalability and cost remain challenges.
SMRTR provides this summary for quick context. The original article belongs to Scientific American.
Read the original article